Johnson & Johnson announces US launch of TECNIS Odyssey IOL

News
Article

The TECNIS Odyssey IOL is a new full vision range IOL built on the TECNIS platform.

Odyssey IOL packaging Image credit: Johnson & Johnson

Image credit: Johnson & Johnson

Johnson & Johnson is expanding the launch of its presbyopia-correcting intraocular lense (IOL), TECNIS Odyssey, in the US.

The TECNIS Odyssey IOL is a new full vision range IOL, built on the TECNIS platform from Johnson & Johnson, which according to the company provides two times better contrast in low lighting than PanOptix.1

Peter Menziuso, company group chairman, Vision, Johnson & Johnson, commented on the launch in a release from the company stating, “More than 14,000 eyes have already benefited from TECNIS Odyssey, our new full visual range IOL. TECNIS Odyssey patients have reported outstanding visual outcomes following surgery, which is why we are excited to announce we are expanding the roll-out across the US. Cataract surgery gives patients a once-in-a-lifetime opportunity to improve their sight, and now with this advanced IOL, patients can see clearly at every distance, without the need for glasses.”

TECNIS Odyssey IOLs feature a unique, freeform diffractive surface designed to eliminate the gaps between near, intermediate, and far distances, which offers continuous, uninterrupted vision at all distances, according to the company. Furthermore, 94% of patients who received the IOL were satisfied with their overall vision without glasses.1

In addition to the launch, Johnson & Johnson is launching the “TECNIS Odyssey IOL Peer Connect" which will allow eye care professionals to engage in live virtual clinical discussions, and will help “foster direct and meaningful medical and scientific conversations regarding TECNIS Odyssey IOL between healthcare professionals with expert surgeons who had early access to the technology.”1

In addition to the US, TECNIS Odyssey IOLs have received regulatory approval in Japan, EU, Korea, Canada, Singapore, Australia and New Zealand.

References:
  1. Johnson & Johnson Rolls Out New TECNIS Odyssey Next-Generation Intraocular Lens Offering Cataract Patients Precise Vision at Every Distance in Any Lighting. Press Release; September 30, 2024. Accessed September 30, 2024. https://www2.multivu.com/johnson-johnson/9293351-en-johnson-and-johnson-vision-tecnis-odyssey
Recent Videos
Katie Rachon, OD, FAAO, Dipl ABO, shares her excitement for the upcoming conference and what it means for an optometrist's toolbox.
EnVision Summit Cochair Cecelia Koetting, OD, FAAO, Dipl ABO, says that attendees should get ready for more discussion-based panels at this year's conference.
From contact lens dropout to addressing diabetic retinopathy in rural communities, optometrists choose an area of eye care research that they would expand, given the appropriate resources.
From new treatments on the horizon for macular degeneration to strengthening comanagement ties, optometrists cite a lot to be excited about in the coming year.
Practice owners testify to the importance of trying new things, not being afraid to fail, and utilizing community as a resource when starting up a new practice.
Optometrists reflect on their residency experiences and provide advice to current residents.
In 2 weeks, the study participant's dry eye symptoms improved from 76 to 43 on a 0-100 rating scale, according to Marc-Matthias Schulze, PhD, Dipl Ing.
Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.
Neda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been prescribing the NutriTears supplement to their dry eye patients.
Damaris Raymondi, OD, FAAO, highlighted the importance of building patient-doctor trust to learn about these practices, which can include non-traditional treatments like chamomile or manuka honey eye drops.
© 2025 MJH Life Sciences

All rights reserved.